Numerous lines of evidence reviewed in the introduction of this CCNMD sugges(that alterations of dopamine (DA) neurotransmission are associated with schizophrenia. Recent development of methods to assess DA neurotransmission in vivo with PET allows direct testing of this hypothesis in patients. The Brain Imaging Core is an integrated team of scientists from various disciplines (chemistry, pharmacology, physics, mathematics), covering the range of expertise needed to develop and support PET neuroreceptor and mouse MRI studies. The services provided to the Center by the Brain Imaging Core fall into three general categories: 1) To provide logistical support and technical expertise to brain imaging projects of the Center. The Core provides expertise at the level of study design, implementation, and analysis. In addition, these studies benefit from the general infrastructure maintained by the Core, such as radiochemistry and image analysis laboratories. 2) To provide training in brain imaging to young investigators. These include young psychiatrists, who are completing a fellowship in the Division of Functional Brain Mapphng as Well as other investigators in the Center who are interested in applying brain imaging techniques to the study of schizophrenia. 3) To develop new imaging modalities that are pertinent to schizophrenia research. Over the next five years, our efforts will be targeted at examining the DA and glutamate systems with PET. We will focus on the following objectives, guided by a general model of neurochemical imbalance associated with schizophrenia described in the Introduction to the Center. a) To continue the characterization of the in vivo properties of the D2 agonist we have radiolabeled; b) To develop a new D1 receptor radiotracer whose binding is affected by acute fluctuations in endogenous DA; c) To develop a radiotracer that labels the NR2B site of the NMDA methods we have applied in other settings to the mouse models of schizophrenia explored in several of the Projects, and f) to continue to refine the voxelwise kinetic modeling methods we have developed. Together, these projects should provide new and sophisticated tools for the study of schizophrenia. The radiotracers and methods developed during this funding cycle of the Center will be made available to the scientific community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH066171-04
Application #
7457816
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2007-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
4
Fiscal Year
2007
Total Cost
$159,115
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Slifstein, Mark; van de Giessen, Elsmarieke; Van Snellenberg, Jared et al. (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72:316-24
Chuhma, Nao; Mingote, Susana; Moore, Holly et al. (2014) Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling. Neuron 81:901-12
Poels, E M P; Kegeles, L S; Kantrowitz, J T et al. (2014) Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol Psychiatry 19:20-9
Poels, Eline M P; Kegeles, Lawrence S; Kantrowitz, Joshua T et al. (2014) Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophr Res 152:325-32
Kisby, Glen E; Moore, Holly; Spencer, Peter S (2013) Animal models of brain maldevelopment induced by cycad plant genotoxins. Birth Defects Res C Embryo Today 99:247-55
Poels, Eline M P; Girgis, Ragy R; Thompson, Judy L et al. (2013) In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 228:167-74
Mihali, Andra; Subramani, Shreya; Kaunitz, Genevieve et al. (2012) Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother 12:785-99
Ward, Ryan D; Simpson, Eleanor H; Richards, Vanessa L et al. (2012) Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 37:1699-707
Abi-Dargham, Anissa; Xu, Xiaoyan; Thompson, Judy L et al. (2012) Increased prefrontal cortical D? receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112. J Psychopharmacol 26:794-805
Li, Yan-Chun; Kellendonk, Christoph; Simpson, Eleanor H et al. (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 108:12107-12

Showing the most recent 10 out of 31 publications